To investigate this hypothesis, we examined upstream promoter regions (−450/+50 of the Transcription Start Site) of genes differentially expressed between GBM TP53 WT samples with high JMJD3 expression versus low JMJD3 expression. Here, KDM6B is linked to glioblastoma.